Page last updated: 2024-10-25

cilostazol and Breast Neoplasms

cilostazol has been researched along with Breast Neoplasms in 3 studies

Breast Neoplasms: Tumors or cancer of the human BREAST.

Research Excerpts

ExcerptRelevanceReference
"Co-treatment with cilostazol prevented paclitaxel-induced dedifferentiation of Schwann cell cultures and demyelination in a mixed culture of Schwann cells and dorsal root ganglia neurons."1.62Cilostazol is an effective causal therapy for preventing paclitaxel-induced peripheral neuropathy by suppression of Schwann cell dedifferentiation. ( Imai, S; Iwamitsu, Y; Koyanagi, M; Matsubara, K; Matsumoto, M; Moriya, A; Nakagawa, S; Nakagawa, T; Nakazato, Y; Ogihara, T; Saigo, M; Yonezawa, A, 2021)
"Considerable evidence suggests that as breast cancer progresses, genetic and epigenetic mechanisms contribute to the emergence of self-renewing cells (CSC), which may also arise as a consequence of metastasis."1.56Phosphodiesterase 3A Represents a Therapeutic Target that Drives Stem Cell-like Property and Metastasis in Breast Cancer. ( Chen, Y; Du, R; Hao, N; Huang, C; Jiang, S; Luo, Y; Shen, W; Shi, Y; Xiang, R; Zhu, J, 2020)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's3 (100.00)2.80

Authors

AuthorsStudies
Haroun, EA1
Mansour, NO1
Eltantawy, A1
Shams, MEE1
Hao, N1
Shen, W1
Du, R1
Jiang, S1
Zhu, J1
Chen, Y1
Huang, C1
Shi, Y1
Xiang, R1
Luo, Y1
Koyanagi, M1
Imai, S1
Iwamitsu, Y1
Matsumoto, M1
Saigo, M1
Moriya, A1
Ogihara, T1
Nakazato, Y1
Yonezawa, A1
Nakagawa, S1
Nakagawa, T1
Matsubara, K1

Trials

1 trial available for cilostazol and Breast Neoplasms

ArticleYear
Effect of cilostazol on preventing paclitaxel-induced neuropathy in patients with breast cancer: A randomized controlled trial.
    Pharmacotherapy, 2023, Volume: 43, Issue:9

    Topics: Breast Neoplasms; Cilostazol; Female; Humans; Nerve Growth Factor; Paclitaxel; Peripheral Nervous Sy

2023

Other Studies

2 other studies available for cilostazol and Breast Neoplasms

ArticleYear
Phosphodiesterase 3A Represents a Therapeutic Target that Drives Stem Cell-like Property and Metastasis in Breast Cancer.
    Molecular cancer therapeutics, 2020, Volume: 19, Issue:3

    Topics: Animals; Apoptosis; Biomarkers, Tumor; Breast Neoplasms; Cell Proliferation; Cilostazol; Cyclic Nucl

2020
Cilostazol is an effective causal therapy for preventing paclitaxel-induced peripheral neuropathy by suppression of Schwann cell dedifferentiation.
    Neuropharmacology, 2021, 05-01, Volume: 188

    Topics: Animals; Blood Proteins; Breast Neoplasms; Cell Dedifferentiation; Cell Line, Tumor; Cilostazol; Dem

2021